NCT00354601: Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer |
|
|
| Terminated | 2 | 2 | US | capecitabine, docetaxel | Wake Forest University Health Sciences, National Cancer Institute (NCI) | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 05/08 | 07/08 | | |
NCT00217529: Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer |
|
|
| Completed | 1/2 | | US | pegfilgrastim, carboplatin, docetaxel, erlotinib hydrochloride | Fred Hutchinson Cancer Center | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 11/05 | | | |
